Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 10, 2024

Primary Completion Date

February 14, 2026

Study Completion Date

April 15, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

Neratinib tablets

In the first week, take Neratinib tablets 120mg orally, in the second week take Neratinib tablets 160mg orally, and from the third week until the end of treatment, take Nilotinib tablets 240mg orally (from Cycle 1 Day 15 until the end of treatment).

All Listed Sponsors
lead

Convalife (Shanghai) Co., Ltd.

INDUSTRY

NCT06519110 - Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations | Biotech Hunter | Biotech Hunter